Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care
Authors
Keywords
-
Journal
CIRCULATION
Volume 139, Issue 25, Pages 2822-2830
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-04-08
DOI
10.1161/circulationaha.118.039177
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Implications of the Propensity Score Matching Paradox in Pharmacoepidemiology
- (2018) John E Ripollone et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Reduced Mortality With Sodium-Glucose Cotransporter–2 Inhibitors in Observational Studies
- (2018) Samy Suissa CIRCULATION
- Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records
- (2018) Elisabetta Patorno et al. DIABETES OBESITY & METABOLISM
- SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
- (2018) Subodh Verma et al. DIABETOLOGIA
- Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
- (2018) Elisabetta Patorno et al. BMJ-British Medical Journal
- Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
- (2018) Elisabetta Patorno et al. BMJ-British Medical Journal
- Use of Health Care Databases to Support Supplemental Indications of Approved Medications
- (2018) Michael Fralick et al. JAMA Internal Medicine
- Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study
- (2018) Dae Hyun Kim et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study
- (2017) Seoyoung C. Kim et al. Arthritis & Rheumatology
- Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.
- (2016) SV Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations
- (2014) Elisabetta Patorno et al. DIABETOLOGIA
- Metrics for covariate balance in cohort studies of causal effects
- (2013) Jessica M. Franklin et al. STATISTICS IN MEDICINE
- One-to-many propensity score matching in cohort studies
- (2012) Jeremy A. Rassen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A systematic review of validated methods for identifying heart failure using administrative data
- (2012) Jane S. Saczynski et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A combined comorbidity score predicted mortality in elderly patients better than existing scores
- (2011) Joshua J. Gagne et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- A basic study design for expedited safety signal evaluation based on electronic healthcare data
- (2010) Sebastian Schneeweiss PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
- (2009) Sebastian Schneeweiss et al. EPIDEMIOLOGY
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
- (2009) Peter C. Austin STATISTICS IN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More